M Evans. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Diabetes Mellitus, Type 2/drug therapyDiabetes Mellitus, Type 2/mortalityDrug Therapy, CombinationHumansHypoglycemic Agents/administration & dosageHypoglycemic Agents/adverse effectsMetformin/administration & dosageMetformin/adverse effectsProspective StudiesRandomized Controlled Trials as TopicSulfonylurea Compounds/administration & dosageSulfonylurea Compounds/adverse effects
Substances: See more » Hypoglycemic AgentsSulfonylurea CompoundsMetformin
Year: 1998 PMID: 9863807 DOI: 10.1016/S0140-6736(05)60422-9
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321